Skip to main content
Livermore
Livermore
ZHEN

Busey Wealth Management

SEC CIK
0001427202
Latest filing
Aug 13, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Busey Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
1,031
Value
$642.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Busey Wealth Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,031$642.9K<0.1%−23−2.2%ReducedHolders
Q1 20261,054$814.4K<0.1%−106−9.1%ReducedHolders
Q4 20251,160$895.4K<0.1%−34−2.8%ReducedHolders
Q3 20251,194$671.4K<0.1%−144−10.8%ReducedHolders
Q2 20251,338$702.5K<0.1%−113−7.8%ReducedHolders
Q1 20251,451$920.3K<0.1%−39−2.6%ReducedHolders
Q4 20241,490$1.06M<0.1%−73−4.7%ReducedHolders
Q3 20241,563$1.64M0.1%−227−12.7%ReducedHolders
Q2 20241,790$1.88M0.1%−92−4.9%ReducedHolders
Q1 20241,882$1.81M0.1%−115−5.8%ReducedHolders
Q4 20231,997$1.75M0.1%+16+0.8%AddedHolders
Q3 20231,981$1.63M0.1%−319−13.9%ReducedHolders
Q2 20232,300$1.65M0.1%−52−2.2%ReducedHolders
Q1 20232,352$1.93M0.1%−67−2.8%ReducedHolders
Q4 20222,419$1.75M0.1%−33−1.3%ReducedHolders
Q3 20222,452$1.69M0.1%−137−5.3%ReducedHolders
Q2 20222,589$1.53M0.1%−387−13.0%ReducedHolders
Q1 20222,976$2.08M0.1%−35−1.2%ReducedHolders
Q4 20213,011$1.90M0.1%−129−4.1%ReducedHolders
Q3 20213,140$1.90M0.1%−332−9.6%ReducedHolders
Q2 20213,472$1.94M0.1%−139−3.8%ReducedHolders
Q1 20213,611$1.71M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.